Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:8-Methoxy-13-hydroxy-9,11-octadecadienoic acid)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004153 AN006894 Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model Feces Rat Shanghai Jiao Tong University LC-MS
ST003877 AN006369 Intestinal permeability of N-acetylcysteine is driven by gut microbiota-dependent cysteine palmitoylation Intestinal fluid Rat Peking University LC-MS
ST002094 AN003421 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
ST000422 AN000667 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic LC-MS
ST000421 AN000663 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic LC-MS
ST000310 AN000490 TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) Blood Mouse Lupus University of Florida LC-MS
ST000310 AN000491 TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) Blood Mouse Lupus University of Florida LC-MS
ST000310 AN000492 TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) Blood Mouse Lupus University of Florida LC-MS
ST000310 AN000493 TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) Blood Mouse Lupus University of Florida LC-MS
ST000047 AN000081 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic LC-MS
ST000046 AN000076 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic LC-MS
ST000046 AN000077 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic LC-MS
  logo